It Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Inputs For Health: Citalopram Dosage: 20 Mg; Escitalopram Oxalate Dosage: 20 Mg; Racealfatocopherol Concentration: 400 Mg; Belimumab Concentration: 120 Mg Pharmaceutical Form: Lyophilized Powder For Injectable; Lacosamide Concentration: 100 Mg; Ribociclib Composition: Succinate, Concentration: 200 Mg; Testosterone Composition: Undecylate Salt, Concentration: 250 Mg/Ml, Pharmaceutical Form: Injectable Solution - 4 Ml; Escitalopram Oxalate Concentration: 20 Mg, Pharmaceutical Form: Orodispersible; Brexpiprazole Concentration: 0.5 Mg; Ibrutinib Concentration: 140 Mg; Acalabrutinib Concentration: 100 Mg; Pembrolizumab Concentration: 25 Mg/Ml Pharmaceutical Form: Solution For Injection - 4 Ml; Osimertinib Concentration: 80 Mg; Plerixafor Concentration: 20 Mg/Ml Pharmaceutical Form: Solution For Injection - 1.2 Ml; Daratumumab Concentration: 20 Mg/Ml, Pharmaceutical Form: Solution For Injection - 5

Ministerio da Saude - Departamento de Logistica em Saude - Coordenacao-Geral de Licitacoes e Contratos de Insumos Estrategicos para Saude Brazil has Released a tender for It Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Inputs For Health: Citalopram Dosage: 20 Mg; Escitalopram Oxalate Dosage: 20 Mg; Racealfatocopherol Concentration: 400 Mg; Belimumab Concentration: 120 Mg Pharmaceutical Form: Lyophilized Powder For Injectable; Lacosamide Concentration: 100 Mg; Ribociclib Composition: Succinate, Concentration: 200 Mg; Testosterone Composition: Undecylate Salt, Concentration: 250 Mg/Ml, Pharmaceutical Form: Injectable Solution - 4 Ml; Escitalopram Oxalate Concentration: 20 Mg, Pharmaceutical Form: Orodispersible; Brexpiprazole Concentration: 0.5 Mg; Ibrutinib Concentration: 140 Mg; Acalabrutinib Concentration: 100 Mg; Pembrolizumab Concentration: 25 Mg/Ml Pharmaceutical Form: Solution For Injection - 4 Ml; Osimertinib Concentration: 80 Mg; Plerixafor Concentration: 20 Mg/Ml Pharmaceutical Form: Solution For Injection - 1.2 Ml; Daratumumab Concentration: 20 Mg/Ml, Pharmaceutical Form: Solution For Injection - 5 in Pharmaceuticals. The tender was released on Aug 10, 2024.

Country - Brazil

Summary - It Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Inputs For Health: Citalopram Dosage: 20 Mg; Escitalopram Oxalate Dosage: 20 Mg; Racealfatocopherol Concentration: 400 Mg; Belimumab Concentration: 120 Mg Pharmaceutical Form: Lyophilized Powder For Injectable; Lacosamide Concentration: 100 Mg; Ribociclib Composition: Succinate, Concentration: 200 Mg; Testosterone Composition: Undecylate Salt, Concentration: 250 Mg/Ml, Pharmaceutical Form: Injectable Solution - 4 Ml; Escitalopram Oxalate Concentration: 20 Mg, Pharmaceutical Form: Orodispersible; Brexpiprazole Concentration: 0.5 Mg; Ibrutinib Concentration: 140 Mg; Acalabrutinib Concentration: 100 Mg; Pembrolizumab Concentration: 25 Mg/Ml Pharmaceutical Form: Solution For Injection - 4 Ml; Osimertinib Concentration: 80 Mg; Plerixafor Concentration: 20 Mg/Ml Pharmaceutical Form: Solution For Injection - 1.2 Ml; Daratumumab Concentration: 20 Mg/Ml, Pharmaceutical Form: Solution For Injection - 5

Deadline - login to view

MT reference number - 90598325

Product classification - Medicinal products for the alimentary tract and metabolism